Condition: Open-Angle Glaucoma · Ocular Hypertension · Sponsor: AbbVie
This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies (192024-091, -092, -093, or -095) and received Bimatoprost SR or who received commercial DURYSTA (Bimatoprost SR) in the open-label Phase 4 ARGOS study (MED-MA-EYE-0648) and completed (or exited early from) the study.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Trinity Research Group /ID# 240190 | Dothan, Alabama, United States | — |
| Arizona Eye Center - West Ray Road /ID# 240239 | Chandler, Arizona, United States | — |
| Arizona Glaucoma Specialists /ID# 240212 | Phoenix, Arizona, United States | — |
| M&M Eye Institute /ID# 240236 | Prescott, Arizona, United States | — |
| Horizon Eye Specialists & Lasik Centers /ID# 240255 | Sun City, Arizona, United States | — |
| Angeles Eye Institute /ID# 250397 | Culver City, California, United States | — |
| Duplicate_Lakeside Vision Center /ID# 240204 | Irvine, California, United States | — |
| Hamilton Glaucoma Center Shiley Eye Center UCSD /ID# 240196 | La Jolla, California, United States | — |
| The Eye Research Foundation /ID# 240186 | Newport Beach, California, United States | — |
| North Bay Eye Associates Inc. /ID# 248912 | Petaluma, California, United States | — |
| Duplicate_Martel Eye Medical Group /ID# 240291 | Rancho Cordova, California, United States | — |
| The Clinical Trials Network (CTNx) /ID# 240284 | Redding, California, United States | — |
+ 112 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.